Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Daiichi Sankyo U.S. CEO Joe Pieroni: An Interview With "The Pink Sheet" DAILY (Part 1 of 2)

This article was originally published in PharmAsia News

Executive Summary

Daiichi Sankyo's head of U.S. operations Joe Pieroni sat down with "The Pink Sheet" DAILY recently at the firm's U.S. headquarters in Parsippany, N.J., to discuss the company's cardiovascular products and pipeline and how the Japanese pharma is looking to the U.S. market as a core growth driver. Pieroni was tapped to lead the newly formed U.S. subsidiary in 2005 following the merger of Daiichi and Sankyo. Previously, Mr. Pieroni had launched Sankyo's U.S. commercial operations, first as president of the Sankyo Parke-Davis joint venture and then as president of Sankyo Pharma Inc., a wholly owned U.S. subsidiary.
Advertisement

Related Content

Daiichi Sankyo Gains U.S. Diabetes Indication For Cholesterol Drug WelChol
Daiichi Sankyo Gains U.S. Diabetes Indication For Cholesterol Drug WelChol
Daiichi Sankyo Submits WelChol sNDA For Diabetes Indication
Daiichi Sankyo Submits Benicar/Amlodipine Fixed-Dose Combination To FDA
Daiichi Sankyo Will Focus On Six Therapeutic Areas
Advertisement
UsernamePublicRestriction

Register

SC066493

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel